Answers are grounded in this paper and cite their sources.
In this phase 2 study of anemia therapy in patients with end-stage renal disease on maintenance hemodialysis therapy, roxadustat was well tolerated and effectively maintained Hb levels.
No takes yet. Share an insight, caveat, or question.
Provenzano et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: